Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Le Qu is a leading figure in urologic oncology, whose research has fundamentally advanced the field of minimally invasive kidney surgery. His primary focus is on the comparative effectiveness of robotic versus open surgical techniques, particularly for partial nephrectomy—a critical procedure for treating kidney tumors while preserving renal function. Dr. Qu’s landmark 2014 systematic review and meta-analysis, cited over 148 times, provided the first comprehensive, high-level evidence demonstrating that robotic partial nephrectomy (RPN) offers superior perioperative outcomes, including reduced blood loss and shorter hospital stays, compared to traditional open surgery. He further validated these findings through rigorous propensity-score matched studies, confirming that RPN achieves comparable early renal functional results with significantly less patient trauma. Beyond comparative studies, Dr. Qu is at the forefront of surgical innovation, as evidenced by his 2025 work exploring the current application and future development of surgical robots. His research has been instrumental in shifting clinical paradigms, establishing robotic surgery as a safe and effective standard of care for kidney cancer patients worldwide.